Literature DB >> 11160352

Expression of chemokine receptors by lung T cells from normal and asthmatic subjects.

J J Campbell1, C E Brightling, F A Symon, S Qin, K E Murphy, M Hodge, D P Andrew, L Wu, E C Butcher, A J Wardlaw.   

Abstract

The lung is an important tertiary lymphoid organ with constant trafficking of T cells through the lung in both health and disease. T cell migration is controlled by a combination of adhesion receptors and chemokines expressed on vascular endothelium and in the tissue, often in an organ-specific manner. This leads to selective accumulation of different T cell subsets, a process called lymphocyte homing. There is evidence for a distinct lung-homing pathway, but no specific lung-homing receptors have been described. We analyzed the chemokine receptor profile of lung T cells to determine the extent to which lung T cells shared homing pathways with other organs such as the gut and skin. In addition, we compared expression of receptors in normal and asthmatic individuals to determine whether different pathways were used in health and disease. We observed that lung T cells expressed a profile of chemokine and adhesion receptors distinct from that of gut- and skin-homing T cells although no chemokine receptor specific for the lung was found. In particular, lung T cells expressed CCR5 and CXCR3, but not CCR9 or cutaneous lymphocyte Ag, and only low levels of CCR4 and alpha(4)beta(7). No differences were observed between lung T cells from normal vs asthmatic subjects. This study provides added support for the concept of a lung-homing pathway separate from other mucosal organs such as the gut and suggests that the chemokine pathways that control T cell migration in normal homeostasis and Th2-type inflammatory responses are similar.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160352     DOI: 10.4049/jimmunol.166.4.2842

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.

Authors:  Robert J Freishtat; Lindsay W Mitchell; Svetlana D Ghimbovschi; Samuel B Meyers; Eric P Hoffman
Journal:  Hum Immunol       Date:  2006-03-27       Impact factor: 2.850

Review 2.  T-cell migration: a naive paradigm?

Authors:  Stephen Cose
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

3.  Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yasuko Fuchimoto; Arihiko Kanehiro; Nobuaki Miyahara; Hikari Koga; Genyo Ikeda; Koichi Waseda; Yasushi Tanimoto; Satoshi Ueha; Mikio Kataoka; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

4.  iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Authors:  Everett H Meyer; Marc-André Wurbel; Tracy L Staton; Muriel Pichavant; Matthew J Kan; Paul B Savage; Rosemarie H DeKruyff; Eugene C Butcher; James J Campbell; Dale T Umetsu
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 5.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

6.  CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

Authors:  Angela J Morgan; Cristina Guillen; Fiona A Symon; Surinder S Birring; James J Campbell; Andrew J Wardlaw
Journal:  Immunobiology       Date:  2008-03-07       Impact factor: 3.144

Review 7.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

8.  Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans.

Authors:  Lyndsey M Muehling; Ronald B Turner; Kenneth B Brown; Paul W Wright; James T Patrie; Sampo J Lahtinen; Markus J Lehtinen; William W Kwok; Judith A Woodfolk
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

9.  Chemokine receptor requirements for epidermal T-cell trafficking.

Authors:  Noah J Tubo; James B McLachlan; James J Campbell
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 10.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.